We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

46 hedge funds and large institutions have $9.06M invested in NantHealth, Inc in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

6% less funds holding

Funds holding: 4946 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

56% less capital invested

Capital invested by funds: $20.5M → $9.06M (-$11.4M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $100K

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1.05%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
15
Reduced
12
Closed
9
Calls
Puts
$100K
Net Calls
-$100K
Net Calls Change
-$19K

NH Hedge Fund Activity: Q3 2018 in Review

46 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q3 2018, worth a combined $9.06M — down 56% from $20.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NH and 6 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 15 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $203K. The largest seller was Morgan Stanley, cutting an estimated $1.07M.

  • 46 institutional investors held NantHealth, Inc (NH) as of Q3 2018, down from 49 in Q2 2018.
  • Funds reported $9.06M of NantHealth, Inc stock for Q3 2018, down 56% quarter-over-quarter.
  • 6 funds opened new NantHealth, Inc positions in Q3 2018 and 9 closed out, a net change of -3 holders.
  • The largest NantHealth, Inc buyer in Q3 2018 was Jacobs Levy Equity Management, an estimated $203K added.
  • The largest NantHealth, Inc seller in Q3 2018 was Morgan Stanley, an estimated $1.07M sold.

Based on aggregated 13F filings for Q3 2018.